TotalMarketCap

Grace Therapeutics

GRCENasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$37.654 M

$1.79 -1.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Grace Therapeutics (GRCE) has a market capitalization of $37.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$7.79M

Loss-making

Shares outstanding

16,274,026

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #351Dogwood TherapeuticsDWTX$39.8M
  2. #352Elicio TherapeuticsELTX$38.1M
  3. #353Grace TherapeuticsGRCE$37.7M
  4. #354Impact BiomedicalIBO$37.6M
  5. #355Aldeyra TherapeuticsALDX$36.7M

What if Grace Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,342,316

Per share 749,897× higher

Bitcoin $1.53T

$72,630.40

Per share 40,576× higher

Apple $5.02T

$238,438.83

Per share 133,206× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Grace Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.